Collectively, these data provide evidence that the dysadherin-fibronectin interaction through the extracellular domain of dysadherin contributes to sustained activation of the fibronectin-integrin-FAK axis in CRC cells. The gene discussed is FXYD5; the disease is colorectal carcinoma.